With the content of better understanding the mechanism of CYP2J2-EETs-sEH metabolic pathway on obesity-induced insulin resistance will provide a therapeutic strategy in combating obesity related metabolic diseases. This evidence concerns the gene EPHX2 and metabolic disease.